SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM

被引：0

作者：

Cohen, Stanley B. ^{[1
]}

van Vollenhoven, Ronald ^{[2
]}

Winthrop, Kevin ^{[3
]}

Zerbini, Cristiano A. F. ^{[4
]}

Tanaka, Yoshiya ^{[5
]}

Bessette, Louis ^{[6
]}

Zhang, Ying ^{[7
]}

Khaff, Nasser ^{[7
]}

Hendrickson, Barbara ^{[7
]}

Enejosa, Jeffrey V. ^{[7
]}

Burmesters, Gerd ^{[8
]}

机构：

[1] Metroplex Clin Res Ctr, Dallas, TX USA

[2] Amsterdam Rheumatol & Immunol Ctr ARC, Amsterdam, Netherlands

[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[4] Ctr Paulista Invest Clin, Sao Paulo, Brazil

[5] Univ Occupat & Environm Hlth, Kitakyushu, Japan

[6] Laval Univ, Quebec City, PQ, Canada

[7] AbbVie Inc, N Chicago, IL USA

[8] Charite, Berlin, Germany

来源：

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2020年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

118

引用

页码：10 / 10

页数：1

共 50 条

[1] SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM
Cohen, Stanley B.
van Vollenhoven, Ronald
Winthrop, Kevin
Zerbini, Cristiano
Tanaka, Yoshiya
Bessette, Louis
Li Yihan
Khan, Nasser
Hendrickson, Barbara
Burmester, Gerd Ruediger
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 357 - 357
[2] Safety Profile of Upadacitinib in Rheumatoid Arthritis: Integrated Analysis from the SELECT Phase 3 Clinical Program
Cohen, Stanley
van Vollenhoven, Ronald
Winthrop, Kevin
Zerbini, Cristiano A.
Tanaka, Yoshiya
Bessette, Louis
Zhang, Ying
Khan, Nasser
Hendrickson, Barbara
Enejosa, Jose Jeffrey
Burmester, Gerd
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[3] SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAMME
Cohen, Stanley B.
van Vollenhoven, Ronald
Winthrop, Kevin
Zerbini, Cristiano
Tanaka, Yoshiya
Bessette, Louis
Zhang, Ying
Khan, Nasser
Hendrickson, Barbara
Enejosa, Jeffrey V.
Burmester, Gerd Rudiger
RHEUMATOLOGY, 2020, 59 : 96 - 96
[4] Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme
Cohen, Stanley B.
van Vollenhoven, Ronald F.
Winthrop, Kevin L.
Zerbini, Cristiano A. F.
Tanaka, Yoshiya
Bessette, Louis
Zhang, Ying
Khan, Nasser
Hendrickson, Barbara
Enejosa, Jeffrey, V
Burmester, Gerd R.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03) : 304 - 311
[5] Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program
Kakehasi, Adriana Maria
Radominski, Sebastiao Cezar
Baravalle, Marcos Daniel
Palazuelos, Fedra Consuelo Irazoque
Garcia-Garcia, Conrado
Arruda, Maysa Silva
Curi, Marco
Liu, John
Qiao, Meihua
Velez-Sanchez, Patricia
Vargas, Juan Ignacio
CLINICAL RHEUMATOLOGY, 2023, 42 (05) : 1249 - 1258
[6] Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program
Adriana Maria Kakehasi
Sebastião Cezar Radominski
Marcos Daniel Baravalle
Fedra Consuelo Irazoque Palazuelos
Conrado Garcia-Garcia
Maysa Silva Arruda
Marco Curi
John Liu
Meihua Qiao
Patricia Velez-Sanchez
Juan Ignacio Vargas
Clinical Rheumatology, 2023, 42 : 1249 - 1258
[7] MACE AND VTE ACROSS MULTIPLE UPADACITINIB STUDIES IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM
Choy, Ernest
McInnes, Lain B.
Cush, John
Aelion, Jacob
Zhang, Ying
Khan, Nasser
Liu, Jianzhong
Camp, Heidi S.
Meerwein, Sebastian
Rigby, William
Cohen, Alexander T.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 11 - 11
[8] MACE and VTE Across Multiple Upadacitinib Studies in Rheumatoid Arthritis: Integrated Analysis from the SELECT Phase 3 Clinical Program
Choy, Ernest
McInnes, Iain
Cush, John
Aelion, Jacob
Zhang, Ying
Khan, Nasser
Liu, Jianzhong
Camp, Heidi
Meerwein, Sebastian
Rigby, William
Cohen, Alexander
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[9] Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme (vol 80, pg 304, 2021)
Cohen, S. B.
van Vollenhoven, R. F.
Winthrop, K. L.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (05)
[10] SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS IN PATIENTS WITH PSORIATIC ARTHRITIS: AN INTEGRATED ANALYSIS FROM THE PHASE 3 PROGRAM
Burmester, G. R.
Winthrop, K.
Blanco, R.
Nash, P.
Goupille, P.
Azevedo, F.
Salvarani, C.
Rubbert-Roth, A.
Lesser, E.
Mccaskill, R.
Liu, J.
Pierre-Louis, B.
Walko, S.
Lippe, R.
Lertratanakul, A.
Ruderman, E.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1287 - 1288

← 1 2 3 4 5 →